Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Aug;11(8):1227-40.
doi: 10.1007/BF00965950.

Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax

Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax

R S Aronstam et al. Neurochem Res. 1986 Aug.

Abstract

The interactions of eighteen natural and synthetic gephyrotoxin and indolizidine alkaloids with binding sites on nicotinic acetylcholine receptor channel (AChR) complex from Torpedo californica electric organ were investigated using two radiolabeled probes, [3H]perhydrohistrionicotoxin and [3H]phencyclidine. Both gephyrotoxins and indolizidines were moderately active inhibitors of the binding of these probes (Ki's = 0.1-20 microM), but did not interact with the acetylcholine binding site. Structure-activity relationships indicate an important contribution of hydrophobic interactions to both gephyrotoxin and indolizidine binding. The stereoconfiguration of the alkaloids had little effect on binding. Carbamylcholine enhanced the affinity of certain alkaloids up to 6 to 8-fold suggesting that interactions with open or desensitized conformations of the AChR complex are favored over interactions with resting conformations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Nat Prod. 1986 Mar-Apr;49(2):265-80 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5754-8 - PubMed
    1. Mol Pharmacol. 1984 May;25(3):395-400 - PubMed
    1. Biochemistry. 1983 Jun 21;22(13):3112-27 - PubMed
    1. Mol Pharmacol. 1984 May;25(3):384-94 - PubMed

Publication types